Skip to main content
SpringerLink
Log in

Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Medicines and Healthcare products Regulatory Agency. Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine. Internet Document : 9 Dec 2020. Available from: URL: https://www.gov.uk/government/news/confirmation-of-guidance-to-vaccinationcentres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine.

  2. Health Canada. Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies. Internet Document : 12 Dec 2020. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/74543a-eng.php.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine. Reactions Weekly 1836, 5 (2021). https://doi.org/10.1007/s40278-021-87824-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-87824-3

Search

Navigation